Annotation Detail

Information
Associated Genes
CRYGD
Associated Variants
LIG1 p.Asp802= (p.D802=) ( ENST00000263274.12, ENST00000427526.6, ENST00000596549.6, ENST00000699866.1, ENST00000699868.1, ENST00000699871.1, ENST00000699874.1, ENST00000699875.1, ENST00000699877.1 )
LIG1 p.Ala170= (p.A170=) ( ENST00000263274.12, ENST00000427526.6, ENST00000596549.6, ENST00000699866.1, ENST00000699868.1, ENST00000699871.1, ENST00000699874.1, ENST00000699875.1, ENST00000699877.1 )
LIG1 c.-7C>T ( ENST00000263274.12, ENST00000427526.6, ENST00000596549.6, ENST00000699866.1, ENST00000699868.1, ENST00000699871.1, ENST00000699874.1, ENST00000699875.1, ENST00000699877.1 )
LIG1 c.-7C>G ( ENST00000263274.12, ENST00000427526.6, ENST00000596549.6, ENST00000699866.1, ENST00000699868.1, ENST00000699871.1, ENST00000699874.1, ENST00000699875.1, ENST00000699877.1 )
LIG1 c.-57-34A>G ( ENST00000263274.12, ENST00000427526.6, ENST00000596549.6, ENST00000699866.1, ENST00000699868.1, ENST00000699871.1, ENST00000699874.1, ENST00000699875.1, ENST00000699877.1 )
LIG1 p.Asp802= (p.D802=) ( ENST00000263274.12, ENST00000427526.6, ENST00000596549.6, ENST00000699866.1, ENST00000699868.1, ENST00000699871.1, ENST00000699874.1, ENST00000699875.1, ENST00000699877.1 )
LIG1 p.Ala170= (p.A170=) ( ENST00000263274.12, ENST00000427526.6, ENST00000596549.6, ENST00000699866.1, ENST00000699868.1, ENST00000699871.1, ENST00000699874.1, ENST00000699875.1, ENST00000699877.1 )
LIG1 c.-7C>T ( ENST00000263274.12, ENST00000427526.6, ENST00000596549.6, ENST00000699866.1, ENST00000699868.1, ENST00000699871.1, ENST00000699874.1, ENST00000699875.1, ENST00000699877.1 )
LIG1 c.-7C>G ( ENST00000263274.12, ENST00000427526.6, ENST00000596549.6, ENST00000699866.1, ENST00000699868.1, ENST00000699871.1, ENST00000699874.1, ENST00000699875.1, ENST00000699877.1 )
LIG1 c.-57-34A>G ( ENST00000263274.12, ENST00000427526.6, ENST00000596549.6, ENST00000699866.1, ENST00000699868.1, ENST00000699871.1, ENST00000699874.1, ENST00000699875.1, ENST00000699877.1 )
Associated Disease
Carcinoma of lung
Source Database
DisGeNET
Description
For lung cancer, when compared to the most common haplotype (rs20581-rs20580-rs20579-rs439132 = T-C-C-A), the adjusted odds ratio (OR) is 1.2 (95% confidence limits (CL) = 0.95, 1.5) for the CACA haplotype, 1.4 (1.0, 1.9) for the CATA haplotype and 1.8 (1.1, 2.8) for the CCCG haplotype, after controlling for age, gender, race/ethnicity, education and tobacco smoking.
Pubmed
18059021
Original source reporting the Gene Disease association
BeFree
DisGENET score for the Gene Disease association
0.00081432561624091
Year of publication
2008
Drugs